Text Version
Entrez PubMed
Overview
Help |
FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central
Privacy Policy
|
|
| 1: |
Aapro MS, van Wijk FH, van der Burg ME, ten Bokkel Huinink W, Vergote I, Guastalla JP, Rosso R, Kobierska A, Beex LV, Namer M, Splinter TE, Vermorken JB. |
Links |
 |
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. Eur J Cancer. 2003 May;39(8):1141-3. PMID: 12736114 [PubMed - indexed for MEDLINE] |
| 2: |
Aapro MS, van Wijk FH, Bolis G, Chevallier B, van der Burg ME, Poveda A, de Oliveira CF, Tumolo S, Scotto di Palumbo V, Piccart M, Franchi M, Zanaboni F, Lacave AJ, Fontanelli R, Favalli G, Zola P, Guastalla JP, Rosso R, Marth C, Nooij M, Presti M, Scarabelli C, Splinter TA, Ploch E, Beex LV, ten Bokkel Huinink W, Forni M, Melpignano M, Blake P, Kerbrat P, Mendiola C, Cervantes A, Goupil A, Harper PG, Madronal C, Namer M, Scarfone G, Stoot JE, Teodorovic I, Coens C, Vergote I, Vermorken JB; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. |
Links |
 |
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol. 2003 Mar;14(3):441-8. PMID: 12598351 [PubMed - indexed for MEDLINE] |
| 6: |
Aleman BM, Raemaekers JM, Tirelli U, Bortolus R, van 't Veer MB, Lybeert ML, Keuning JJ, Carde P, Girinsky T, van der Maazen RW, Tomsic R, Vovk M, van Hoof A, Demeestere G, Lugtenburg PJ, Thomas J, Schroyens W, De Boeck K, Baars JW, Kluin-Nelemans JC, Carrie C, Aoudjhane M, Bron D, Eghbali H, Smit WG, Meerwaldt JH, Hagenbeek A, Pinna A, Henry-Amar M; European Organization for Research and Treatment of Cancer Lymphoma Group. |
Links |
 |
Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med. 2003 Jun 12;348(24):2396-406. PMID: 12802025 [PubMed - indexed for MEDLINE] |
| 11: |
Baas P, Ardizzoni A, Grossi F, Nackaerts K, Numico G, Van Marck E, van de Vijver M, Monetti F, Smid-Geirnaerdt MJ, van Zandwijk N, Debruyne C, Legrand C, Giaccone G; EORTC Lung Cancer Group. |
Links |
 |
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992). Eur J Cancer. 2003 Feb;39(3):353-7. PMID: 12565988 [PubMed - indexed for MEDLINE] |
| 18: |
Bartelink H, Benz C, Cleveland D, Dorn R, Gralow J, Gradishar WJ, Grant K, Heimann R, Hellman S, Hudis C, Kerbel R, Lippman M, Lung J, Posner MC, Steeg P, Vestal R, Weichselbaum RR, Zetter B. |
Links |
 |
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul;80(2):139-44. Review. No abstract available. PMID: 12908816 [PubMed - indexed for MEDLINE] |
| 30: |
Bonnefoi H, Diebold-Berger S, Therasse P, Hamilton A, van de Vijver M, MacGrogan G, Shepherd L, Amaral N, Duval C, Drijkoningen R, Larsimont D, Piccart M. |
Links |
 |
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome? Ann Oncol. 2003 Mar;14(3):406-13. PMID: 12598346 [PubMed - indexed for MEDLINE] |
| 31: |
Bouma M, Nuijen B, Harms R, Rice JR, Nowotnik DP, Stewart DR, Jansen BA, van Zutphen S, Reedijk J, van Steenbergen MJ, Talsma H, Bult A, Beijnen JH. |
Links |
 |
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280. Drug Dev Ind Pharm. 2003 Oct;29(9):981-95. PMID: 14606662 [PubMed - indexed for MEDLINE] |
| 34: |
Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, Burns HJ, Christensen L, Denis L, Dicato M, Diehl V, Doll R, Franceschi S, Gillis CR, Gray N, Griciute L, Hackshaw A, Kasler M, Kogevinas M, Kvinnsland S, La Vecchia C, Levi F, McVie JG, Maisonneuve P, Martin-Moreno JM, Bishop JN, Oleari F, Perrin P, Quinn M, Richards M, Ringborg U, Scully C, Siracka E, Storm H, Tubiana M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze DG, Zatonski W, zur Hausen H. |
Links |
 |
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol. 2003 Jul;14(7):973-1005. No abstract available. PMID: 12853336 [PubMed - indexed for MEDLINE] |
| 46: |
Carlin S, Mairs RJ, McCluskey AG, Tweddle DA, Sprigg A, Estlin C, Board J, George RE, Ellershaw C, Pearson AD, Lunec J, Montaldo PG, Ponzoni M, van Eck-Smit BL, Hoefnagel CA, van den Brug MD, Tytgat GA, Caron HN. |
Links |
 |
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. Clin Cancer Res. 2003 Aug 15;9(9):3338-44. PMID: 12960120 [PubMed - indexed for MEDLINE] |
| 56: |
Crul M, Schoemaker NE, Pluim D, Maliepaard M, Underberg RW, Schot M, Sparidans RW, Baas P, Beijnen JH, Van Zandwijk N, Schellens JH. |
Links |
 |
Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3526-33. PMID: 14506138 [PubMed - in process] |
| 58: |
Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA; European Working Group for Breast Screening Pathology. |
Links |
 |
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003 Aug;39(12):1654-67. Review. PMID: 12888359 [PubMed - indexed for MEDLINE] |
| 64: |
de Gast GC, Batchelor D, Kersten MJ, Vyth-Dreese FA, Sein J, van de Kasteele WF, Nooijen WJ, Nieweg OE, de Waal MA, Boogerd W. |
Links |
 |
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma. Br J Cancer. 2003 Jan 27;88(2):175-80. PMID: 12610499 [PubMed - indexed for MEDLINE] |
| 80: |
Eberhardt WE, Albain KS, Pass H, Putnam JB, Gregor A, Assamura H, Mornex F, Senan S, Belderbos J, Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J, Rocmans P, Shepherd FA. |
Links |
 |
Induction treatment before surgery for non-small cell lung cancer. Lung Cancer. 2003 Dec;42 Suppl 1:S9-14. Review. PMID: 14708516 [PubMed - indexed for MEDLINE] |
| 92: |
Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ. |
Links |
 |
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003 Oct;52(10):1479-86. PMID: 12970142 [PubMed - indexed for MEDLINE] |
| 93: |
Fentiman IS, Christiaens MR, Paridaens R, Van Geel A, Rutgers E, Berner J, de Keizer G, Wildiers J, Nagadowska M, Legrand C, Therasse P; EORTC. |
Links |
 |
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer. 2003 Feb;39(3):309-16. PMID: 12565982 [PubMed - indexed for MEDLINE] |
| 97: |
Fossa SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Group 30941; Medical Research Council Testicular Cancer Study Group TE20. |
Links |
 |
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol. 2003 Mar 15;21(6):1107-18. PMID: 12637478 [PubMed - indexed for MEDLINE] |
| 105: |
Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B, Joensuu T, Lynch CF, Curtis RE, Holowaty E, Storm H, Pukkala E, van't Veer MB, Fraumeni JF, Boice JD Jr, Clarke EA, Travis LB. |
Links |
 |
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res. 2003 Feb;159(2):161-73. PMID: 12537521 [PubMed - indexed for MEDLINE] |
| 108: |
Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Lugovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL, Villasenor J, Mehrotra B, Chen J, Rao VR, Brugge JS, Ferguson CG, Payrastre B, Myszka DG, Cantley LC, Wagner G, Divecha N, Prestwich GD, Yuan J. |
Links |
 |
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell. 2003 Jul 11;114(1):99-111. PMID: 12859901 [PubMed - indexed for MEDLINE] |
| 111: |
Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, Hart AA, van Oers MH, van der Hulst M, Baars JW, Bartelink H. |
Links |
 |
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol. 2003 Jul 1;21(13):2474-80. PMID: 12829665 [PubMed - indexed for MEDLINE] |
| 120: |
Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP. |
Links |
 |
The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia. 2003 Nov-Dec;5(6):495-506. PMID: 14965443 [PubMed - indexed for MEDLINE] |
| 121: |
Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G. |
Links |
 |
Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 2003 Apr 1;63(7):1449-53. PMID: 12670888 [PubMed - indexed for MEDLINE] |
| 135: |
Kaivo-Oja N, Bondestam J, Kamarainen M, Koskimies J, Vitt U, Cranfield M, Vuojolainen K, Kallio JP, Olkkonen VM, Hayashi M, Moustakas A, Groome NP, ten Dijke P, Hsueh AJ, Ritvos O. |
Links |
 |
Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J Clin Endocrinol Metab. 2003 Feb;88(2):755-62. PMID: 12574210 [PubMed - indexed for MEDLINE] |
| 138: |
Kitamura K, Shirato H, Seppenwoolde Y, Shimizu T, Kodama Y, Endo H, Onimaru R, Oda M, Fujita K, Shimizu S, Miyasaka K. |
Links |
 |
Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):221-8. PMID: 12694842 [PubMed - indexed for MEDLINE] |
| 141: |
Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ. |
Links |
 |
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003 Oct;54(4):514-20. PMID: 14520665 [PubMed - indexed for MEDLINE] |
| 153: |
Kruijtzer CM, Boot H, Beijnen JH, Lochs HL, Parnis FX, Planting AS, Pelgrims JM, Williams R, Mathot RA, Rosing H, Schot ME, Van Tinteren H, Schellens JH. |
Links |
 |
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer. Ann Oncol. 2003 Feb;14(2):197-204. PMID: 12562644 [PubMed - indexed for MEDLINE] |
| 200: |
Offerhaus GJ, Correa P, van Eeden S, Geboes K, Drillenburg P, Vieth M, van Velthuysen ML, Watanabe H, Sipponen P, ten Kate FJ, Bosman FT, Bosma A, Ristimaki A, van Dekken H, Riddell R, Tytgat GN. |
Links |
 |
Report of an Amsterdam working group on Barrett esophagus. Virchows Arch. 2003 Nov;443(5):602-8. Epub 2003 Sep 27. Review. No abstract available. PMID: 14517678 [PubMed - indexed for MEDLINE] |
| 204: |
Orian A, van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LW, Cowley SM, Yost C, Pierce S, Edgar BA, Parkhurst SM, Eisenman RN. |
Links |
 |
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 2003 May 1;17(9):1101-14. Epub 2003 Apr 14. PMID: 12695332 [PubMed - indexed for MEDLINE] |
| 206: |
Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC, Heimann DM, Klebanoff CA, Yu Z, Hwang LN, Feigenbaum L, Kruisbeek AM, Rosenberg SA, Restifo NP. |
Links |
 |
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med. 2003 Aug 18;198(4):569-80. PMID: 12925674 [PubMed - indexed for MEDLINE] |
| 210: |
Peters GJ, Noordhuis P, Van Kuilenburg AB, Schornagel JH, Gall H, Turner SL, Swart MS, Voorn D, Van Gennip AH, Wanders J, Holwerda U, Smid K, Giaccone G, Fumoleau P, Van Groeningen CJ. |
Links |
 |
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors. Cancer Chemother Pharmacol. 2003 Jul;52(1):1-12. Epub 2003 May 09. PMID: 12739060 [PubMed - indexed for MEDLINE] |
| 211: |
Peters PJ, Mironov A Jr, Peretz D, van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M, Prusiner SB. |
Links |
 |
Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol. 2003 Aug 18;162(4):703-17. PMID: 12925711 [PubMed - indexed for MEDLINE] |
| 219: |
Postmus PE, Rocmans P, Asamura H, Ball D, Belderbos J, Cappello M, Jassem J, Novello S, Pass H, Passlick B, Pirker R, Ready N, Sause W, Scagliotti G, Vansteenkiste J, Westeel V, van Zandwijk N. |
Links |
 |
Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. Lung Cancer. 2003 Dec;42 Suppl 1:S3-6. Review. No abstract available. PMID: 14708514 [PubMed - indexed for MEDLINE] |
| 229: |
Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, Janssen H, Calafat J, Drijfhout JW, Neefjes J. |
Links |
 |
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity. 2003 Jan;18(1):97-108. PMID: 12530979 [PubMed - indexed for MEDLINE] |
| 230: |
Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, Ottenhoff TH, Neefjes J, Schumacher TN, Hutt-Fletcher LM, Wiertz EJ. |
Links |
 |
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11583-8. Epub 2003 Sep 22. PMID: 14504389 [PubMed - indexed for MEDLINE] |
| 233: |
Rodenhuis S, Bontenbal M, Beex LV, Wagstaff J, Richel DJ, Nooij MA, Voest EE, Hupperets P, van Tinteren H, Peterse HL, TenVergert EM, de Vries EG; Netherlands Working Party on Autologous Transplantation in Solid Tumors. |
Links |
 |
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med. 2003 Jul 3;349(1):7-16. PMID: 12840087 [PubMed - indexed for MEDLINE] |
| 245: |
Schellens JH, Planting AS, van Zandwijk N, Ma J, Maliepaard M, van der Burg ME, de Boer-Dennert M, Brouwer E, van der Gaast A, van den Bent MJ, Verweij J. |
Links |
 |
Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer. Br J Cancer. 2003 Mar 24;88(6):814-21. PMID: 12644815 [PubMed - indexed for MEDLINE] |
| 256: |
Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE, Cornelissen JJ, Schaafsma MR, van Oers MH, Wijermans PW, Fibbe WE, Wittebol S, Schouten HC, van Marwijk Kooy M, Biesma DH, Baars JW, Slater R, Steijaert MM, Buijt I, Lokhorst HM; Dutch-Belgian Hemato-Oncology Cooperative Study Group. |
Links |
 |
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood. 2003 Mar 15;101(6):2144-51. Epub 2002 Nov 27. PMID: 12456509 [PubMed - indexed for MEDLINE] |
| 267: |
Stokvis E, Nan-Offeringa L, Rosing H, Lopez-Lazaro L, Acena JL, Miranda E, Lyubimov A, Levine BS, D'Aleo C, Schellens JH, Beijnen JH. |
Links |
 |
Quantitative analysis of ES-285, an investigational marine anticancer drug, in human, mouse, rat, and dog plasma using coupled liquid chromatography and tandem mass spectrometry. J Mass Spectrom. 2003 May;38(5):548-54. PMID: 12794877 [PubMed - indexed for MEDLINE] |
| 268: |
Strom E, Solin LJ, Vicini FA, Taylor ME, Olivotto IA, Haffty BG, Pierce LJ, Marks LB, Jhingran A, Wai ES, Bijker N, Harry B. |
Links |
 |
Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S240-1. No abstract available. PMID: 12965521 [PubMed - in process] |
| 269: |
Suh N, Roberts AB, Birkey Reffey S, Miyazono K, Itoh S, ten Dijke P, Heiss EH, Place AE, Risingsong R, Williams CR, Honda T, Gribble GW, Sporn MB. |
Links |
 |
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Cancer Res. 2003 Mar 15;63(6):1371-6. PMID: 12649201 [PubMed - indexed for MEDLINE] |
| 281: |
Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E. |
Links |
 |
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003 Jul 23;290(4):465-75. Erratum in: JAMA. 2003 Sep 10;290(10):1318. PMID: 12876089 [PubMed - indexed for MEDLINE] |
| 283: |
Twelves C, Hoekman K, Bowman A, Vermorken JB, Anthoney A, Smyth J, van Kesteren C, Beijnen JH, Uiters J, Wanders J, Gomez J, Guzman C, Jimeno J, Hanauske A. |
Links |
 |
Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. Eur J Cancer. 2003 Sep;39(13):1842-51. PMID: 12932661 [PubMed - indexed for MEDLINE] |
| 292: |
van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H. |
Links |
 |
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 2003 Jun;4(6):609-15. PMID: 12776180 [PubMed - indexed for MEDLINE] |
| 293: |
van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B. |
Links |
 |
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol. 2003 Apr;14(4):599-602. PMID: 12649108 [PubMed - indexed for MEDLINE] |
| 294: |
Van den Brande J, Schoffski P, Schellens JH, Roth AD, Duffaud F, Weigang-Kohler K, Reinke F, Wanders J, de Boer RF, Vermorken JB, Fumoleau P. |
Links |
 |
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer. Br J Cancer. 2003 Mar 10;88(5):648-53. PMID: 12659110 [PubMed - indexed for MEDLINE] |
| 309: |
van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS. |
Links |
 |
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003 Jul 2;95(13):971-80. PMID: 12837833 [PubMed - indexed for MEDLINE] |
| 315: |
van Rijswijk RE, Vermorken JB, Reed N, Favalli G, Mendiola C, Zanaboni F, Mangili G, Vergote I, Guastalla JP, ten Bokkel Huinink WW, Lacave AJ, Bonnefoi H, Tumulo S, Rietbroek R, Teodorovic I, Coens C, Pecorelli S. |
Links |
 |
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923). Eur J Cancer. 2003 Mar;39(4):481-7. PMID: 12751379 [PubMed - indexed for MEDLINE] |
|